Lopinavir/ritonavir did not shorten the duration of SARS CoV-2 shedding in patients with mild pneumonia in Taiwan
oleh: Chien-Yu Cheng, Yu-Lin Lee, Cheng-Pin Chen, Yi-Chun Lin, Chun-Eng Liu, Chia-Hung Liao, Shu-Hsing Cheng
| Format: | Article |
|---|---|
| Diterbitkan: | Elsevier 2020-06-01 |
Deskripsi
An increase of Ct values was 0.9 per day in 2 cases of COVID-19 treated with lopinavir/ritonavir (LPV/r), an increase was 1.0 per day in 3 cases without LPV/r through illness day 1–10, indicating that LPV/r did not shorten the duration of SARS CoV-2 shedding.